GENEVA, April 17 -- APTACURE THERAPEUTICS LIMITED (M13, 1/F, Unit 101-103, Building 15 of Hong Kong Science Park, No.15 Science Park West Avenue, Pak Shek Kok, New TerritoriesHong Kong), 安沛治疗有限公司 (中国香港特别行政区新界科学园西大街科学园15号楼101-103单元1楼M13) filed a patent application (PCT/CN2025/126462) for "APTAMER CONJUGATE FOR TARGETED DEGRADATION OF DKK1" on Oct 09, 2025. With publication no. WO/2026/077382, the details related to the patent application was published on Apr 16, 2026.
Notably, the patent application was submitted ...